Americans can’t afford their medications. About 25% leave prescriptions unfilled, split pills, or skip doses. Seniors face challenges covering non-Medicare services, including prescriptions. Even those with commercial health insurance are not immune. One-third of…
Continue Reading
Deep neural networks have been integrated into the whole clinical decision procedure which can improve the efficiency of diagnosis and alleviate the heavy workload of physicians. Since most neural networks are supervised, their performance…
Continue Reading
In 2020, the U.S. Department of Defense officially disclosed a set of ethical principles to guide the use of Artificial Intelligence (AI) technologies on future battlefields. Despite stark differences, there are core similarities between…
Continue Reading
AI development powerhouse Nvidia is launching a new set of cloud-based application programming interfaces (APIs) designed to speed up the creation and deployment of specialized AI models in the medical imaging field. The company…
Continue Reading
It has been a very good year for Limbic, winner of the scale-up category in Pitchfest 2023. CEO Ross Harper explains how their AI innovation is improving access to mental health support, and the…
Continue Reading
The next public health pronouncement or clinical treatment might emerge from synthetic data: rows of totally invented people that contain no real data but reflects the actual characteristics of a population such as race,…
Continue Reading
The next public health pronouncement or clinical treatment might emerge from synthetic data: rows of totally invented people that contain no real data but reflects the actual characteristics of a population such as race,…
Continue Reading
Ibex Logo
What You Should Know:
– Dedalus Group, an anatomic pathology information systems provider in Europe, and Ibex Medical Analytics, a market leader in AI-powered cancer diagnostics, have jointly launched an integrated End-to-End AI-powered Digital…
Continue Reading
German pharmaceutical company Boehringer Ingelheim and tech giant IBM are teaming up to harness the power of genAI and foundation models to further biologic drug discovery.The partnership leverages IBM’s foundation model technologies, consisting of…
Continue Reading
